Subscribe on your favorite platform:
Real-world data plays a vital role in the pharmaceutical industry, and it can immensely support clinical research and drug development. However, a centralized and coordinated data strategy could make a more significant impact.
In this episode of the Real World Talk podcast, our host Miruna Sasu welcomes Marisa Co, Head of R&D Business Insights and Analytics, and David Anstatt, Vice President of Real-world Analytics & Data Science, at Bristol-Myers Squibb. They talk about the value of centralized real-world data, why data is an asset for enterprises, and the importance of collaboration in the pharma space.